Virtus ETF Advisers LLC Abb Vie Inc. Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $157,554 - $196,066	-1,189 Reduced 19.9%	4,785 $644,000
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $104,263 - $120,075	721 Added 13.73%	5,974 $952,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $90,593 - $108,644	655 Added 14.25%	5,253 $849,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $19,594 - $22,473	-146 Reduced 3.08%	4,598 $617,000
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $652,869 - $830,010	4,744 New	4,744 $727,000
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $12,252 - $16,396	-167 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $13,609 - $20,633	-211 Reduced 55.82%	167 $13,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $27,265 - $34,114	378 New	378 $33,000

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.